Status: Recruiting
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
This study is a multicenter, randomized, open-label, parallel-group phase III clinical trial comparing the efficacy and safety of GZR18 Injection and semaglutide (Wegovy®) in adult obese or overweight subjects, aiming to evaluate the efficacy and safety of GZR18 Injection in this population.
Participants needed: 420
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Gan & Lee Pharmaceuticals.Updated: Nov 25, 2025Locations: 1
Eligibility criteria
Aged ≥ 18 years old (based on the date of signing the informed consent form), ma... [+5]
Fasting plasma glucose ≥ 7.0 mmol/L or glycated hemoglobin (HbA1c) ≥ 6.5% as mea... [+15]